Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 1 to 10 of 388

TitlePrioritisation programmeDecisionDecision date
Pegunigalsidase alfa every 4 weeks for treating Fabry disease [TSID12346]Medicines evaluationNot selected
Siponimod for treating multiple sclerosis in people 10 to 17 years [TSID12317]Medicines evaluationNot selected
Ruxolitinib for treating acute graft-versus-host disease after allogeneic stem cell transplant in people 28 days to 17 years [ID6410]Medicines evaluationNot selected
Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma in people aged 12 to 17 [TSID11839]Medicines evaluationNot selected
Peginterferon alfa-2a for treating polycythaemia vera or essential thrombocythaemia [TSID12325]Medicines evaluationNot selected
Dronabinol for treating muscle spasticity in multiple sclerosis after 2 treatments [TSID10638]Medicines evaluationNot selected
Dabrafenib for treating unresectable or metastatic BRAF V600 mutation positive melanoma in people 12 to 17 years [TSID12399]Medicines evaluationNot selected
Dabrafenib with trametinib for treating unresectable or metastatic BRAF V600 mutation positive melanoma in people 12 to 17 years [TSID12398]Medicines evaluationNot selected
Wireless breast lesion localization using Savi Scout seedInterventional proceduresAwaiting decision
CT hepatic arteriography for patients undergoing percutaneous ablation of primary or secondary liver tumoursInterventional proceduresAwaiting decision

Results per page

  1. 10
  2. 25
  3. 50
  4. All